GO:0048643 positive regulation of skeletal muscle tissue development: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048643 describes any process that activates, maintains, or increases the rate of skeletal muscle tissue development.
• Positive regulation of skeletal muscle development is driven by coordinated signaling from Wnt/β-catenin, RNF138, and myoblast fusion machinery.
• Muscle satellite cells are the primary stem cell population whose activation and differentiation are positively regulated during development and regeneration.
• Dysregulation of this process contributes to neuromuscular disorders, muscle atrophy, and pediatric rhabdomyosarcoma.
• MicroRNAs such as miR-486 and ion channels like TRPV2 fine-tune the positive regulation of muscle development and remodeling.
• CRISPR-based knockout, knock-in, and overexpression models are essential for dissecting causal genes in this GO term.
Description
Skeletal muscle tissue development is a highly orchestrated biological process that requires the precise positive regulation of myogenic commitment, proliferation, differentiation, and fusion. The Gene Ontology term GO:0048643, positive regulation of skeletal muscle tissue development, captures any process that activates, maintains, or increases the rate of this developmental program. Understanding this term is critical for researchers studying muscle regeneration, exercise adaptation, and neuromuscular disease, because the same signaling nodes that drive normal development are often reactivated or corrupted in pathology. The positive regulation of skeletal muscle development is not a single molecular event but a network of extracellular cues, intracellular signaling cascades, and transcriptional programs that converge on myogenic regulatory factors. Key positive regulators include Wnt/β-catenin signaling, which promotes myoblast differentiation and fusion, and the myoblast fusion machinery that is essential for forming multinucleated myofibers. Satellite cells, the resident muscle stem cells, must be activated and then positively regulated to enter the myogenic program. Disruption of these positive regulatory inputs leads to impaired muscle growth, failed regeneration, and diseases such as inclusion body myositis and rhabdomyosarcoma. This article provides a research-grade synthesis of GO:0048643, integrating authoritative QuickGO annotation with real PubMed literature to support experimental design and therapeutic hypothesis generation.
positive regulation of skeletal muscle tissue development At A Glance
| GO ID | GO:0048643 |
|---|---|
| GO term | positive regulation of skeletal muscle tissue development |
| Ontology | biological_process |
| Definition | Any process that activates, maintains or increases the rate of skeletal muscle tissue development. |
| Synonyms | activation of skeletal muscle development; stimulation of skeletal muscle development; up regulation of skeletal muscle development; up-regulation of skeletal muscle development; upregulation of skeletal muscle development |
| Major function | Positive control of myogenic differentiation, myoblast fusion, and myofiber maturation |
| Related processes | Wnt/β-catenin signaling, satellite cell activation, myoblast fusion, muscle regeneration |
| Disease relevance | Neuromuscular disorders, muscle atrophy, rhabdomyosarcoma, inclusion body myositis |
What Is GO:0048643?
GO:0048643, positive regulation of skeletal muscle tissue development, is a biological process term defined as any process that activates, maintains, or increases the rate of skeletal muscle tissue development. In practical terms, it encompasses the molecular signals, transcription factors, and cellular behaviors that push muscle progenitor cells toward differentiation and fusion, rather than inhibiting or halting these events. This term is a child of positive regulation of developmental process and is distinct from the broader skeletal muscle tissue development term because it specifically requires a net positive effect on the rate or extent of muscle formation.
Why Is positive regulation of skeletal muscle tissue development Important in Cell Biology?
Positive regulation of skeletal muscle tissue development is fundamental to organismal growth, metabolic health, and regeneration. Because skeletal muscle accounts for a large fraction of body mass and is essential for locomotion and glucose homeostasis, understanding how this process is positively regulated has direct implications for treating muscle wasting, sarcopenia, and neuromuscular disease. Moreover, the same pathways that positively regulate development are often hijacked in pediatric cancers such as rhabdomyosarcoma, making this GO term a bridge between developmental biology and oncology.
• Defines the molecular logic by which muscle stem cells are instructed to differentiate rather than remain quiescent.
• Provides a framework for understanding exercise-induced muscle hypertrophy and protein metabolism.
• Links Wnt/β-catenin signaling to myoblast fusion and myofiber formation.
• Explains how microRNAs such as miR-486 modulate muscle atrophy and exercise adaptation.
• Highlights TRPV2 as a calcium-dependent regulator of satellite cell function and muscle remodeling.
• Connects failed positive regulation to inclusion body myositis and age-related muscle regeneration defects.
• Offers therapeutic targets for rhabdomyosarcoma, where developmental programs are aberrantly reactivated.
• Guides CRISPR experimental design for causal gene validation in myogenesis.
What Happens During positive regulation of skeletal muscle tissue development?
Satellite cell activation and entry into the myogenic program
In simple terms: Muscle stem cells wake up and start becoming muscle.
In response to injury or developmental cues, satellite cells are activated from quiescence and begin expressing myogenic regulatory factors. Positive regulation at this stage ensures that satellite cells commit to the myogenic lineage rather than returning to quiescence or adopting a fibrogenic fate. Dysfunction of satellite cells is a hallmark of several neuromuscular disorders, underscoring the importance of positive regulatory inputs. Calcium signaling through TRPV2 in satellite cells is crucial for skeletal muscle remodeling, demonstrating that ion channels can act as positive regulators of this early step.
Wnt/β-catenin signaling drives myoblast differentiation
In simple terms: A chemical signal tells muscle precursor cells to mature.
The Wnt/β-catenin pathway is a well-established positive regulator of skeletal muscle differentiation. RNF138 has been shown to regulate skeletal muscle differentiation via the Wnt/β-catenin signaling pathway, providing a direct molecular link between ubiquitin ligase activity and positive regulation of myogenesis. Activation of β-catenin in myoblasts promotes the expression of myogenic genes and enhances the rate of differentiation, consistent with the definition of GO:0048643.
Myoblast fusion and myofiber formation
In simple terms: Individual muscle cells merge to form larger, functional muscle fibers.
Myoblast fusion is a critical step in skeletal muscle development and regeneration. Positive regulation of this fusion reaction is required for the formation of multinucleated myofibers. Millay (2022) reviewed the regulation of the myoblast fusion reaction, highlighting that positive regulators include actin cytoskeleton remodeling proteins and membrane fusion machinery. Without positive regulation at this step, myoblasts may differentiate but fail to form functional myofibers.
MicroRNA-mediated fine-tuning of muscle development
In simple terms: Small RNA molecules adjust the strength of muscle-building signals.
Muscle-enriched microRNAs such as miR-486 act as positive regulators of muscle development and exercise adaptation. Qiu et al. (2024) demonstrated that miR-486 mediates regulation of muscular atrophy and exercise, indicating that microRNAs can positively regulate muscle tissue development by targeting negative regulators or enhancing anabolic signaling. This layer of regulation ensures that muscle development is responsive to physiological demand.
Metabolic and exercise-induced positive regulation
In simple terms: Exercise and nutrition can boost muscle growth.
Exercise and protein metabolism are potent positive regulators of muscle growth. Tipton et al. (2001) reviewed how exercise and protein metabolism interact to promote muscle growth, establishing that mechanical loading and amino acid availability positively regulate muscle tissue development. This physiological regulation operates through mTOR signaling and is essential for adaptations to training.
Key Genes Involved in GO:0048643 positive regulation of skeletal muscle tissue development
The following genes and proteins are experimentally validated positive regulators or markers of skeletal muscle tissue development, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RNF138 | E3 ubiquitin ligase that positively regulates myoblast differentiation via Wnt/β-catenin | Knockout and overexpression models to test causal role in myogenesis |
| CTNNB1 | β-catenin, core transcriptional co-activator of Wnt signaling | Point mutations to stabilize or ablate β-catenin in muscle cells |
| MYOD1 | Myogenic regulatory factor, master transcription factor for myogenesis | Knockout and knock-in reporter models for differentiation tracking |
| MYOG | Myogenin, promotes terminal differentiation and fusion | Overexpression and knockout to assess fusion efficiency |
| MYF5 | Early myogenic determination factor | Lineage tracing and conditional knockout |
| PAX7 | Satellite cell marker and regulator of quiescence | Knock-in reporter for satellite cell isolation |
| TRPV2 | Calcium-permeable ion channel in satellite cells | Knockout and point mutation to test calcium-dependent remodeling |
| MIR486 | Muscle-enriched microRNA regulating atrophy and exercise | Overexpression and sponge knockdown in muscle cells |
| MEF2C | Transcription factor cooperating with MYOD for muscle gene expression | Knockout and knock-in for enhancer studies |
| IGF1 | Growth factor promoting muscle hypertrophy | Overexpression models for positive regulation |
| MTOR | Kinase integrating nutrient and mechanical signals | Point mutation and knockout for anabolic signaling |
| FOXO1 | Transcription factor promoting atrophy; negatively regulated by positive signals | Knockout to enhance positive regulation |
| SMAD2/3 | TGF-β effectors that inhibit myogenesis; their inhibition is positive regulation | Knockout and point mutation for pathway crosstalk |
| NCAM1 | Adhesion molecule involved in myoblast fusion | Knockout for fusion assays |
| MYH1 | Myosin heavy chain, marker of mature myofibers | Knock-in fluorescent reporter for fiber typing |
| DES | Desmin, intermediate filament in muscle cytoskeleton | Knockout for structural integrity studies |
| DMD | Dystrophin, links cytoskeleton to membrane | Knockout models for muscular dystrophy |
| MYF6 | Myogenic factor 6, involved in myofiber maturation | Overexpression for maturation studies |
How Is positive regulation of skeletal muscle tissue development Regulated?
Positive regulation of skeletal muscle tissue development is itself regulated at multiple levels. Upstream, Wnt ligands and β-catenin activity are controlled by secreted antagonists and ubiquitin-proteasome degradation; RNF138 modulates this pathway to promote differentiation. Calcium influx through TRPV2 in satellite cells provides a second messenger that can activate downstream kinases and transcription factors. MicroRNAs such as miR-486 post-transcriptionally tune the expression of genes involved in atrophy and hypertrophy, effectively setting the threshold for positive regulation. Systemically, exercise and protein intake regulate mTOR signaling, which integrates nutrient availability with muscle protein synthesis and growth. Finally, pathological states such as inclusion body myositis show disturbed muscle regeneration with altered proteome signatures, indicating that positive regulation is compromised in disease.
positive regulation of skeletal muscle tissue development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RNF138 | Impaired myoblast differentiation | Knockout and overexpression in C2C12 cells |
| TRPV2 | Defective satellite cell remodeling | Conditional knockout in mouse satellite cells |
| MIR486 | Muscle atrophy and exercise response | Overexpression and sponge knockdown in vivo |
| PAX7 | Satellite cell-opathy | Knock-in lineage tracing and knockout |
| CTNNB1 | Rhabdomyosarcoma differentiation block | Point mutation and knockout in tumor models |
Neuromuscular disorders and satellite cell dysfunction
Many neuromuscular disorders are characterized by satellite cell dysfunction, which impairs the positive regulation of skeletal muscle tissue development. Ganassi et al. (2022) described an expanding portfolio of satellite cell-opathies, where defects in satellite cell activation, proliferation, or differentiation lead to failed muscle regeneration. In inclusion body myositis, ageing signatures and disturbed muscle regeneration are associated with altered proteome profiles, suggesting that positive regulatory pathways are disrupted.
Pediatric rhabdomyosarcoma
Rhabdomyosarcoma is a pediatric cancer that resembles arrested skeletal muscle development. Single-cell transcriptomic profiling has identified tumor-acquired and therapy-resistant cell states in pediatric rhabdomyosarcoma, including subpopulations that retain myogenic differentiation programs. Positive regulation of skeletal muscle tissue development is therefore relevant to understanding why some tumor cells fail to differentiate and how differentiation therapy might be designed.
Muscle atrophy and exercise adaptation
Muscle atrophy results from an imbalance between protein synthesis and degradation, often due to reduced positive regulation of muscle tissue development. miR-486 is muscle-enriched and mediates regulation of muscular atrophy and exercise, highlighting a microRNA-based mechanism that can be targeted to enhance positive regulation. Exercise and protein metabolism are physiological positive regulators that counteract atrophy.
From positive regulation of skeletal muscle tissue development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is RNF138 required for myoblast differentiation? | RNF138 knockout C2C12 myoblasts |
| Does TRPV2 calcium signaling regulate satellite cell activation? | TRPV2 conditional knockout mouse |
| Can miR-486 overexpression prevent muscle atrophy? | miR-486 overexpression in mouse muscle |
| Does β-catenin stabilization enhance myogenesis? | CTNNB1 point mutation knock-in |
| What is the role of myoblast fusion proteins in development? | Knockout of fusion machinery in zebrafish or mouse |
| How does exercise regulate mTOR in muscle? | mTOR point mutation knock-in mouse |
How to Study the positive regulation of skeletal muscle tissue development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptome changes | Identify positive regulators during differentiation |
| Single-cell RNA-seq | Cell state heterogeneity | Map satellite cell activation trajectories |
| Proteomics | Protein abundance and modifications | Discover biomarkers in muscle disease |
| Immunofluorescence | Protein localization and fusion index | Quantify myoblast fusion |
| Calcium imaging | Intracellular calcium dynamics | Assess TRPV2 function in satellite cells |
| CRISPR knockout screen | Gene essentiality for differentiation | Unbiased discovery of positive regulators |
| Western blot | Protein expression and signaling | Validate Wnt/β-catenin activation |
| qRT-PCR | mRNA levels of myogenic factors | Measure MyoD and myogenin expression |
Transcriptomic profiling of myogenesis
RNA-seq and single-cell RNA-seq can capture the transcriptional changes that occur during positive regulation of skeletal muscle tissue development. Danielli et al. (2024) used single-cell transcriptomic profiling to identify cell states in pediatric rhabdomyosarcoma, demonstrating how this method can reveal developmental trajectories and therapy-resistant populations. In normal myogenesis, RNA-seq of satellite cells at different activation states can identify positive regulators.
Proteomic analysis of muscle regeneration
Mass spectrometry-based proteomics measures protein abundance and post-translational modifications. de Vries et al. (2025) applied muscle proteomics to inclusion body myositis and identified ageing signatures and disturbed muscle regeneration, illustrating how proteomics can uncover biomarkers of impaired positive regulation.
Imaging and fusion assays
Immunofluorescence and live-cell imaging are essential for quantifying myoblast fusion and myofiber formation. Millay (2022) reviewed assays for the myoblast fusion reaction, including membrane staining and nuclei counting, which directly measure the output of positive regulation. Calcium imaging with TRPV2 reporters can visualize signaling events in satellite cells.
Functional genomics with CRISPR screens
CRISPR knockout screens enable unbiased discovery of positive regulators of skeletal muscle development. By introducing genome-wide guide RNAs into myoblasts and selecting for differentiation markers, researchers can identify genes whose loss impairs myogenesis. This approach complements candidate-based studies of RNF138 and Wnt/β-catenin.
How CRISPR Can Be Used to Study GO:0048643 positive regulation of skeletal muscle tissue development
Knockout
CRISPR knockout of candidate positive regulators such as RNF138 or TRPV2 allows researchers to test whether loss of function impairs skeletal muscle differentiation or satellite cell activation. For example, RNF138 knockout in myoblasts would be expected to reduce Wnt/β-catenin signaling and differentiation efficiency. TRPV2 knockout in satellite cells can reveal defects in calcium-dependent remodeling.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to activate/stabilize proteins. For CTNNB1, a point mutation that prevents phosphorylation and degradation can stabilize β-catenin, leading to enhanced positive regulation of myogenesis. Similarly, point mutations in mTOR can be used to dissect nutrient-sensing inputs.
Knock-in
Knock-in of fluorescent reporters or epitope tags at endogenous loci enables real-time tracking of positive regulators. A PAX7-GFP knock-in mouse allows isolation of satellite cells for downstream assays. Tagging MYOD1 or MYOG with luciferase can provide a readout of differentiation in high-throughput screens.
Overexpression
Overexpression of positive regulators such as miR-486 or IGF1 can enhance muscle development and counteract atrophy. CRISPR activation (CRISPRa) can be used to overexpress endogenous genes without transgenesis, providing a powerful tool to test sufficiency of a candidate positive regulator.
How EDITGENE Supports positive regulation of skeletal muscle tissue development Research
Researchers studying positive regulation of skeletal muscle tissue development-related genes often need to determine whether a candidate gene is causally involved in myogenesis, whether a specific mutation alters its function, or whether its overexpression is sufficient to drive differentiation. EDITGENE provides end-to-end CRISPR services to answer these questions with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of skeletal muscle tissue development research.
Frequently Asked Questions About positive regulation of skeletal muscle tissue development
What is GO:0048643?
GO:0048643 is the Gene Ontology term for positive regulation of skeletal muscle tissue development, defined as any process that activates, maintains, or increases the rate of skeletal muscle tissue development.
What genes are involved in positive regulation of skeletal muscle tissue development?
Key genes include RNF138, CTNNB1 (β-catenin), MYOD1, MYOG, PAX7, TRPV2, and MIR486, among others.
How does Wnt/β-catenin signaling regulate muscle development?
Wnt/β-catenin signaling promotes myoblast differentiation; RNF138 positively regulates this pathway to enhance skeletal muscle differentiation.
What are muscle satellite cells?
Satellite cells are resident muscle stem cells that are activated to proliferate and differentiate during muscle development and regeneration.
What diseases are linked to defective positive regulation of muscle development?
Neuromuscular disorders, inclusion body myositis, muscle atrophy, and pediatric rhabdomyosarcoma are linked to defects in this process.
How can CRISPR be used to study muscle development?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate genes in myogenesis.
What is the role of TRPV2 in muscle satellite cells?
TRPV2 is a calcium channel in satellite cells that is crucial for skeletal muscle remodeling.
How does exercise positively regulate muscle development?
Exercise and protein metabolism stimulate muscle protein synthesis and growth, positively regulating muscle tissue development.
What is miR-486 and how does it affect muscle?
miR-486 is a muscle-enriched microRNA that mediates regulation of muscular atrophy and exercise adaptation.
What methods are used to study positive regulation of skeletal muscle development?
Common methods include RNA-seq, single-cell RNA-seq, proteomics, immunofluorescence, calcium imaging, and CRISPR screens.
Conclusion
GO:0048643, positive regulation of skeletal muscle tissue development, is a central biological process that integrates signaling pathways, transcription factors, microRNAs, and cellular behaviors to drive muscle formation. Understanding its molecular players, from RNF138 and Wnt/β-catenin to TRPV2 and miR-486, provides a foundation for therapeutic strategies in muscle disease and cancer. CRISPR-based models are indispensable for moving from correlation to causation in this field.
References
- 1. Tipton KD et al.. 2001. Exercise, protein metabolism, and muscle growth.. Int J Sport Nutr Exerc Metab 11(1):109-32 PMID: 11255140
- 2. Ganassi M et al.. 2022. Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies.. Eur J Transl Myol 32(1) PMID: 35302338
- 3. Danielli SG et al.. 2024. Single cell transcriptomic profiling identifies tumor-acquired and therapy-resistant cell states in pediatric rhabdomyosarcoma.. Nat Commun 15(1):6307 PMID: 39060228
- 4. Wang W et al.. 2025. RNF138 regulates skeletal muscle differentiation via the Wnt/β-catenin signaling pathway.. Theranostics 15(10):4446-4464 PMID: 40225576
- 5. Millay DP. 2022. Regulation of the myoblast fusion reaction for muscle development, regeneration, and adaptations.. Exp Cell Res 415(2):113134 PMID: 35367215
- 6. Qiu D et al.. 2024. Muscle-enriched microRNA-486-mediated regulation of muscular atrophy and exercise.. J Physiol Biochem 80(4):795-809 PMID: 39222208
- 7. Chen Y et al.. 2025. TRPV2 in muscle satellite cells is crucial for skeletal muscle remodelling.. Cell Death Dis 16(1):888 PMID: 41397955
- 8. de Vries GM et al.. 2025. Ageing Signatures and Disturbed Muscle Regeneration in Muscle Proteome of Inclusion Body Myositis.. J Cachexia Sarcopenia Muscle 16(3):e13845 PMID: 40485189
